Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Prevalent comorbidities among young and underprivileged: Death portrait of COVID-19 among 235 555 hospitalized patients in Brazil

View ORCID ProfileEduardo Pietre, View ORCID ProfileGabriel P Amorim, View ORCID ProfileMaria F F Bittencourt, View ORCID ProfileMarcelo Ribeiro-Alves, View ORCID ProfileMariana Acquarone
doi: https://doi.org/10.1101/2021.01.22.21250346
Eduardo Pietre
1Faculdade de Medicina de Petrópolis - FMP, Petrópolis, RJ, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eduardo Pietre
Gabriel P Amorim
1Faculdade de Medicina de Petrópolis - FMP, Petrópolis, RJ, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gabriel P Amorim
Maria F F Bittencourt
1Faculdade de Medicina de Petrópolis - FMP, Petrópolis, RJ, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maria F F Bittencourt
Marcelo Ribeiro-Alves
3Instituto Nacional de Infectologia Evandro Chagas. Fundação Oswaldo Cruz, Rio de Janeiro, RJ, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marcelo Ribeiro-Alves
Mariana Acquarone
1Faculdade de Medicina de Petrópolis - FMP, Petrópolis, RJ, Brazil
2Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mariana Acquarone
  • For correspondence: macquarone@gmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Background

COVID-19 has been alarmingly spreading worldwide, with Brazil ranking third in total number of cases and second in deaths. Being a continental country, which comprises many ethnic groups and an engrained social inequality, the pandemic evidenced this heterogeneous discrepancy. We aimed to estimate the impact of associated risk factors, isolated or combined, on COVID-19 severeness, detecting specific epidemiological profiles for multiple age ranges in hospitalized Brazilians.

Methods In this large retrospective cohort study, we used open-access data from the Ministry of Health of Brazil with COVID-19 confirmed hospitalized patients annotated in SRAG system between February and August 2020, a total of 235555 entries. The association of COVID-19 death with socio-demographic and clinical characteristics was analysed and presented as odds ratios adjusted by confounding co-variables. We also presented marginal mean aOR values for high-order interactions either by or not another fixed level or condition. We kept all other variables in the multivariate logistic models in their mean values or equal proportions.

Findings Younger individuals with one or more comorbidities had an adjusted odds ratio up to four-fold compared to those without it, in the same age interval. Younger diabetic patients either self-declared as brown ethnicity (aOR 5·58, 95% CI 4·97-6·25; p<0·0001) or with some other associated comorbidities, mainly chronic hematologic disease (21·09, 13·64-32·6; p<0·0001) and obesity (aOR 21·7, 95% CI not calculated; p<0·0001), resulted in outstanding death risk. Age over 60, particularly over 90 (28·91, 24·5-34·11; p<0.001), usage of invasive ventilatory support (16·23, 14·05-18·75; p<0·001), admission to intensive care units (3·14, 2·82-3·48; p<0·001), multiple respiratory symptoms (3·24, 2·79-3·75; p<0·0001), black ethnicity (1·78, 1·52-2·07; p<0·05), and diagnosis previous to hospitalization (1·32, 1·19-1·47; p<0·05) were associated with higher death odds. As protective factors, with roughly one third less death risk, we found hospitalization duration of (4, 7] days and illness onset to hospitalization over 6 days.

Interpretation We found evidence for increased COVID-19 risk in two distinct groups: younger patients with prevalent comorbidities, especially in brown ethnicity, and patients with black ethnicity. We speculate that the pro-inflammatory synergism of COVID-19 and comorbidities, promoting an overproduction of cytokines, is partially the cause of higher mortality in this young group. Brazilian black and brown are underprivileged populations, with structural social inequality, limited healthcare access and, thus, remarkable disease vulnerability. Our study supplies essential data to patient stratification upon admission, optimizing hospital management, and to guide public policy determinations, including group prioritization for COVID-19 vaccination in Brazil.

Funding None.

Research in context

Evidence before this study

Evidence before this study COVID-19 is still very active, having spread to over two hundred countries and caused more than one million deaths worldwide. Its current situation requires large-scale studies to assess the impact of preexisting comorbidities, symptoms, and socioeconomic issues regarding mortality rate, especially where lack of control is evident. We searched PubMed, Google Scholar, medRxiv, and bioRxiv on Dec 12, 2020, for studies published in English or Brazilian Portuguese, estimating the impact of several risk factors in COVID-19 prognosis. We used the search terms “Brazil” or “risk factors” or “ethnicity” or “cohort” or “diabetes mellitus” or “mortality” or “symptoms” or “comorbidities”, and related synonyms, combined with “SARS-CoV-2” or “COVID-19”. Many pre-existing conditions have shown to directly impact patient prognosis, out of which cancer, chronic kidney disease, chronic obstructive pulmonary disease, cardiovascular disease, obesity, and diabetes, among others, are well established in SARS-CoV-2 infection severeness. Some studies reported an increased death risk for non-white Brazilians, but no large scale cohort analyzing the impact of one or more associated risk factors in younger Brazilians patients were found.

Added value of this study

Added value of this study We found that the impact of having one or two or more risk factors on mortality are progressively higher in ages (60, 80], (40, 60], (20, 40], and (0, 20], compared with people of the same age interval without comorbidities. We also found that young brown individuals with diabetes, as well as black ethnicity on its own, are population subgroups at remarkably higher risk for severe COVID-19 in Brazil. Furthermore, advanced age, usage of ventilatory support, admission to intensive care units, multiple respiratory symptoms, and diagnosis previous to hospitalization were associated with higher death odds. As protective factors, we found hospitalization duration of (4, 7] days and illness onset to hospitalization over 6 days.

Implications of all the available evidence

Implications of all the available evidence We identified multiple epidemiological profiles associated with death risk in different age ranges in Brazilian COVID-19 hospitalized patients. These findings unveil that a large part of Brazilian working-age population is at a higher risk for SARS-CoV-2 death, a neglected situation that is further exacerbating inequalities, leading to a striking sociodemographic and economic impact. We hope that our analysis aids patient risk stratification, hospital management optimization, and public policy determination, including prioritization for COVID-19 vaccination in Brazil.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Funding: None.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

I confirm all relevant ethical guidelines have been followed.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

DATA SHARING SRAG data is publicly available on the Ministry of Health of Brazil website. The analysis source code will be available upon request to the authors.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted January 25, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Prevalent comorbidities among young and underprivileged: Death portrait of COVID-19 among 235 555 hospitalized patients in Brazil
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Prevalent comorbidities among young and underprivileged: Death portrait of COVID-19 among 235 555 hospitalized patients in Brazil
Eduardo Pietre, Gabriel P Amorim, Maria F F Bittencourt, Marcelo Ribeiro-Alves, Mariana Acquarone
medRxiv 2021.01.22.21250346; doi: https://doi.org/10.1101/2021.01.22.21250346
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Prevalent comorbidities among young and underprivileged: Death portrait of COVID-19 among 235 555 hospitalized patients in Brazil
Eduardo Pietre, Gabriel P Amorim, Maria F F Bittencourt, Marcelo Ribeiro-Alves, Mariana Acquarone
medRxiv 2021.01.22.21250346; doi: https://doi.org/10.1101/2021.01.22.21250346

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (580)
  • Anesthesia (141)
  • Cardiovascular Medicine (1970)
  • Dentistry and Oral Medicine (253)
  • Dermatology (188)
  • Emergency Medicine (336)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (704)
  • Epidemiology (11134)
  • Forensic Medicine (8)
  • Gastroenterology (632)
  • Genetic and Genomic Medicine (3205)
  • Geriatric Medicine (310)
  • Health Economics (570)
  • Health Informatics (2055)
  • Health Policy (864)
  • Health Systems and Quality Improvement (793)
  • Hematology (311)
  • HIV/AIDS (687)
  • Infectious Diseases (except HIV/AIDS) (12750)
  • Intensive Care and Critical Care Medicine (708)
  • Medical Education (320)
  • Medical Ethics (92)
  • Nephrology (339)
  • Neurology (3006)
  • Nursing (167)
  • Nutrition (466)
  • Obstetrics and Gynecology (592)
  • Occupational and Environmental Health (614)
  • Oncology (1566)
  • Ophthalmology (478)
  • Orthopedics (189)
  • Otolaryngology (267)
  • Pain Medicine (204)
  • Palliative Medicine (57)
  • Pathology (404)
  • Pediatrics (916)
  • Pharmacology and Therapeutics (387)
  • Primary Care Research (357)
  • Psychiatry and Clinical Psychology (2811)
  • Public and Global Health (5624)
  • Radiology and Imaging (1104)
  • Rehabilitation Medicine and Physical Therapy (637)
  • Respiratory Medicine (765)
  • Rheumatology (342)
  • Sexual and Reproductive Health (316)
  • Sports Medicine (291)
  • Surgery (351)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (133)